(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or 5 prevention of cancer, a neurological disease or condition, or a viral infection. B-A N...

Full description

Saved in:
Bibliographic Details
Main Authors Valls Vidal, Nuria, Estiarte Martinez, Maria de los Angeles, Fyfe, Matthew Colin Thor, Castro Palomino Laria, Julio Cesar, Kurz, Guido, Martinell Pedemonte, Marc, Ortega Munoz, Alberto
Format Patent
LanguageEnglish
Published 16.05.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or 5 prevention of cancer, a neurological disease or condition, or a viral infection. B-A NH-L2-D
Bibliography:Application Number: AU20170254889